The effect of Erythropoietin Alfa in traumatic brain injury

Phase 3

• Conditions: Traumatic Brain Injury.; External causes of morbidity and mortality; V01-Y98

• Registration Number: IRCT201204149462N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Inclusion and exclusion Criteria were as follows: Patients with blunt head trauma; GCS equal or less than 13 in admission time; patient admitted in hospital less than 8 hours after trauma

Exclusion Criteria

Patient’s GCS above 13 in admission time; patients with GCS=3 and pupils without reaction to light in admission time; penetrating head injury; O2-Sat bellow 90% in admission time; admission after 8 hours of injury; any critical injury in any part of the body except for head; patient with history of CPR before the intervention; any kind of severe pre-existing systemic co-morbidity; history of hypersensitivity to any injected drug; any patients with drug history of anticoagulant therapy; age under 4 years or above 70 years

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GCS score. Timepoint: Admission time, 24 hourse. 7 days. Method of measurement: Clinical assessment (Physical examination).

Secondary Outcome Measures

Name	Time	Method
Glasgow Outcome Scale Score. Timepoint: 6th mounth. Method of measurement: Clinical assessment (Physical examination).;Decrease in hospital stay. Timepoint: Day of discharge. Method of measurement: days.